Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2019 8
2020 7
2021 10
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Results by year
Filters applied: . Clear all
Page 1
A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast Cancer.
Yuan Y, Lee JS, Yost SE, Frankel PH, Ruel C, Egelston CA, Guo W, Gillece JD, Folkerts M, Reining L, Highlander SK, Robinson K, Padam S, Martinez N, Tang A, Schmolze D, Waisman J, Sedrak M, Lee PP, Mortimer J. Yuan Y, et al. Among authors: yost se. Oncologist. 2021 Feb;26(2):99-e217. doi: 10.1002/onco.13583. Epub 2020 Nov 24. Oncologist. 2021. PMID: 33141975 Free PMC article. Clinical Trial.
Physics approaches to the spatial distribution of immune cells in tumors.
Yu CC, Wortman JC, He TF, Solomon S, Zhang RZ, Rosario A, Wang R, Tu TY, Schmolze D, Yuan Y, Yost SE, Li X, Levine H, Atwal G, Lee PP. Yu CC, et al. Among authors: yost se. Rep Prog Phys. 2021 Feb;84(2):022601. doi: 10.1088/1361-6633/abcd7b. Rep Prog Phys. 2021. PMID: 33232952
Co-stimulatory and co-inhibitory immune markers in solid tumors with MET alterations.
Reckamp KL, McQuerry JA, Mambetsariev I, Pharaon R, Yost SE, Fricke J, Mirzapoiazova T, Pillai RK, Khan Z, Fakih M, Yuan Y, Koczywas M, Massarelli E, Kulkarni P, Pal SK, Sattler M, Bild A, Salgia R. Reckamp KL, et al. Among authors: yost se. Future Sci OA. 2020 Nov 25;7(2):FSO662. doi: 10.2144/fsoa-2020-0159. Future Sci OA. 2020. PMID: 33437521 Free PMC article.
Phase II Trial of Neoadjuvant Carboplatin and Nab-Paclitaxel in Patients with Triple-Negative Breast Cancer.
Yuan Y, Lee JS, Yost SE, Li SM, Frankel PH, Ruel C, Schmolze D, Robinson K, Tang A, Martinez N, Stewart D, Waisman J, Kruper L, Jones V, Menicucci A, Uygun S, Yoder E, van der Baan B, Yim JH, Yeon C, Somlo G, Mortimer J. Yuan Y, et al. Among authors: yost se. Oncologist. 2021 Mar;26(3):e382-e393. doi: 10.1002/onco.13574. Epub 2020 Nov 8. Oncologist. 2021. PMID: 33098195 Free PMC article. Clinical Trial.
Evaluation of Somatic Mutations in Solid Metastatic Pan-Cancer Patients.
Roosan MR, Mambetsariev I, Pharaon R, Fricke J, Baroz AR, Chao J, Chen C, Nasser MW, Chirravuri-Venkata R, Jain M, Smith L, Yost SE, Reckamp KL, Pillai R, Arvanitis L, Afkhami M, Wang EW, Chung V, Cristea M, Fakih M, Koczywas M, Massarelli E, Mortimer J, Yuan Y, Batra SK, Pal S, Salgia R. Roosan MR, et al. Among authors: yost se. Cancers (Basel). 2021 Jun 3;13(11):2776. doi: 10.3390/cancers13112776. Cancers (Basel). 2021. PMID: 34204917 Free PMC article.
Mutation and immune profiling of metaplastic breast cancer: Correlation with survival.
Afkhami M, Schmolze D, Yost SE, Frankel PH, Dagis A, Amanam IU, Telatar M, Nguyen K, Yu KW, Luu T, Pillai R, Aoun PA, Mortimer J, Yuan Y. Afkhami M, et al. Among authors: yost se. PLoS One. 2019 Nov 6;14(11):e0224726. doi: 10.1371/journal.pone.0224726. eCollection 2019. PLoS One. 2019. PMID: 31693690 Free PMC article.
Metabolic syndrome risk components and mortality after triple-negative breast cancer diagnosis in postmenopausal women in the Women's Health Initiative.
Yuan Y, Pan K, Mortimer J, Chlebowski RT, Luo J, Yan JE, Yost SE, Kroenke CH, Adams-Campbell L, Nassir R, Sun Y, Shadyab AH, Vitolins MZ, Saquib N, Wild RA, Manson JE, Nelson RA. Yuan Y, et al. Among authors: yost se. Cancer. 2021 May 15;127(10):1658-1667. doi: 10.1002/cncr.33407. Epub 2021 Jan 21. Cancer. 2021. PMID: 33476042
23 results